Huntsville, Ala. | December 6, 2016 – CFD Research Corporation has been awarded a $1M contract from the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) to develop countermeasures for Aflatoxin B1 (AFB1) mycotoxin threats.
“Aflatoxins B1 (AFB1) are fungal produced mycotoxins that are present in food supplies and are strongly associated with increased risk for the development of liver cancer,” said Dr. Narender Singh, CFDRC senior research scientist and principal investigator. “Currently, there are no known countermeasures to selectively mitigate AFB1 toxicity.” 
To meet this challenge, in previous work, CFDRC successfully validated a proof-of-concept study to harness the microbiome extracts of scavenging mammals for bioactive natural products as potential AFB1 countermeasures.
Read the full release here.
